Showing results (71-80 of 369) with videos related to
Sort By:
Pageof 37
Journal of Hematotherapy & Stem Cell Research|January 25, 2000
T lymphocyte transduction with herpes simplex virus-thymidine kinase (HSV-tk) gene: comparison of four different infection protocolsM Di Ianni, S Di Florio, G Venditti, et al.Journal of Hematotherapy & Stem Cell Research|January 25, 2000
The alterations of the activities of coagulation inhibitors and fibrinolytic factors in stored cord blood could affect the yield of progenitor cells during processingY H Lee, J Y Han, A H Choi, et al.Journal of Hematotherapy & Stem Cell Research|May 17, 2000
Immunologic methods of purging in autologous stem cell transplantationL BerkahnJournal of Hematotherapy & Stem Cell Research|May 17, 2000
Osmometric and permeability characteristics of human placental/umbilical cord blood CD34+ cells and their application to cryopreservationE J Woods, J Liu, C W Derrow, et al.Journal of Hematotherapy & Stem Cell Research|May 17, 2000
The clinical and biologic significance of abnormal lipid profiles in patients with myelodysplastic syndromesK Allampallam, D Dutt, C Nair, et al.Journal of Hematotherapy & Stem Cell Research|May 17, 2000
Prevalence of MLR blocking antibodies before and after immunotherapyS Agrawal, M K Pandey, A PandeyJournal of Hematotherapy & Stem Cell Research|May 17, 2000
A randomized trial of leukapheresis volumes, 7 L versus 10 L: an assessment of efficacy and patient toleranceA P Schwarer, N M Messino, M Gibson, et al.Journal of Hematotherapy & Stem Cell Research|May 3, 2000
Expression of the adhesion molecules CD49d and CD49e on G-CSF-mobilized CD34+ cells of patients with solid tumors or non-Hodgkin's and Hodgkin's lymphoma and of healthy donors is inversely correlated with the amount of mobilized CD34+ cellsW Zeller, N Kröger, J Berger, et al.Journal of Hematotherapy & Stem Cell Research|May 22, 2001
Characterization of a new monoclonal antibody 6G7 that recognizes a unique antigen on myeloid and lymphoid cellsJ Chen, J H Zhou, E D BallJournal of Hematotherapy & Stem Cell Research|May 22, 2001
CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cellsL Kobari, M C Giarratana, F Pflumio, et al.Pageof 37